Diabetic foot infections and antibiotic therapy (Q35592333)

9 August 2017

1 reference

title

Diabetic foot infections and antibiotic therapy (English)

1 reference

9 August 2017

1

Thomas Zgonis

1 reference

9 August 2017

Gary Peter Jolly

2

1 reference

9 August 2017

Benjamin J Buren

series ordinal

3

1 reference

9 August 2017

Peter Blume

series ordinal

4

1 reference

9 August 2017

publication date

1 October 2003

1 reference

Clinics in podiatric medicine and surgery

9 August 2017

published in

1 reference

9 August 2017

volume

20

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

655-669

1 reference

Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Diagnostic strategies in osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Comparison of Tc-99m-labelled antileukocyte fragment Fab' and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Chronic complicated osteomyelitis of the lower extremity: evaluation with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Tendon involvement in pedal infection: MR analysis of frequency, distribution, and spread of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Nonenhancing tissue on MR imaging of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Systematic review of antimicrobial agents used for chronic wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Evidence-based antibiotic therapy of diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Osteomyelitis of the foot in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Conservative management of osteomyelitis in the feet of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Piperacillin/tazobactam therapy for diabetic foot infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Management and outcome of severe diabetic foot infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Outpatient management of uncomplicated lower-extremity infections in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Diabetes and the risk of infection-related mortality in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

Foot infections in diabetic patients. Decision and cost-effectiveness analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-8422%2803%2900067-3

7 January 2021

10.1016/S0891-8422(03)00067-3

Identifiers

DOI

1 reference

9 August 2017

1 reference